SIRS-ESWT Trial: Shoulder Internal Rotator Spasticity Trial Treated With Extracorporeal Shock Wave Therapy Trial

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Nov 3, 2024

Keywords

ClinConnect Summary

The SIRS-ESWT Trial is studying a treatment called Extracorporeal Shock Wave Therapy (ESWT) to see if it can help reduce muscle stiffness in the shoulders of patients who have had a stroke. This stiffness, known as spasticity, can make it difficult for people to move their arms freely. The trial is looking for participants who are at least 18 years old, have had a stroke affecting one side of their body, and experience limited movement in their shoulder. Participants will need to be in stable health and able to follow instructions.

If you or someone you know qualifies for this trial, you can expect to receive focused shock wave treatment aimed at improving shoulder movement. The study is currently recruiting participants, and it’s important to note that individuals with certain medical conditions, such as multiple strokes or specific brain disorders, may not be eligible. This trial is a chance to explore a new approach to managing shoulder spasticity after a stroke, which could potentially improve quality of life for those affected.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged 18 years or older with unilateral cerebral stroke.
• • Restricted passive external rotation of the spastic shoulder by more than 20 degrees.
• • A Modified Ashworth Scale score of 1 or higher for shoulder internal rotator spasticity.
• • Stable medical condition and vital signs.
• • Clear consciousness, able to follow instructions.
• Exclusion Criteria:
• • History of two or more strokes, traumatic brain injury, brain tumors, or other cerebral disorders.
• • Coexisting central nervous system disorders (e.g., spinal cord injury, Parkinson's disease) or other musculoskeletal conditions affecting muscle tone assessment.
• • Ineligibility for shock wave intervention due to malignancies, coagulation disorders, localized infections, or presence of a pacemaker.
• • Prior shock wave intervention or botulinum toxin injection for post-stroke spasticity within the past three months.
• • Inability to participate in interventions or functional assessments due to cognitive, consciousness, or language impairments.